{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:51:23Z","timestamp":1790049083641,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["statutory work"],"award-info":[{"award-number":["statutory work"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12882-016-0392-6","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T08:50:40Z","timestamp":1479199840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism"],"prefix":"10.1186","volume":"17","author":[{"given":"Piotr","family":"Kuczera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Adamczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wi\u0119cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"392_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116:1202\u20139.","journal-title":"J Clin Invest"},{"key":"392_CR2","doi-asserted-by":"publisher","unstructured":"Zhu D, Mackenzie NC, Millan JL, et al. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS ONE. doi: \n                    10.1371\/journal.pone.0019595","DOI":"10.1371\/journal.pone.0019595"},{"key":"392_CR3","first-page":"317","volume":"22","author":"R Koos","year":"2013","unstructured":"Koos R, Brandenburg V, Mahnken AH, et al. Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study. J Heart Valve Dis. 2013;22:317\u201325.","journal-title":"J Heart Valve Dis"},{"key":"392_CR4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/ndt\/gfs466","volume":"28","author":"R Kramann","year":"2013","unstructured":"Kramann R, Brandenburg VM, Schurgers LJ, et al. Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy. Nephrol Dial Transplant. 2013;28:856\u201368.","journal-title":"Nephrol Dial Transplant"},{"key":"392_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1086\/318811","volume":"68","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Gardner JC, Van NJ, et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet. 2001;68:577\u201389.","journal-title":"Am J Hum Genet"},{"key":"392_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/jmg.39.2.91","volume":"39","author":"W Balemans","year":"2002","unstructured":"Balemans W, Patel N, Ebeling M, et al. Identification of a 52\u00a0kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet. 2002;39:91\u20137.","journal-title":"J Med Genet"},{"key":"392_CR7","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido T, Ali AA, Gubrij I, et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology. 2005;146:4577\u201383.","journal-title":"Endocrinology"},{"key":"392_CR8","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1210\/jc.2009-2283","volume":"95","author":"FS Mirza","year":"2010","unstructured":"Mirza FS, Padhi ID, Raisz LG, et al. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab. 2010;95:1991\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"392_CR9","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1210\/jc.2013-1521","volume":"98","author":"KJ Claes","year":"2013","unstructured":"Claes KJ, Viaene L, Heye S, et al. Sclerostin: another vascular calcification inhibitor? J Clin Endocrinol Metab. 2013;98:3221\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"392_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2215\/CJN.07670712","volume":"8","author":"S Pelletier","year":"2013","unstructured":"Pelletier S, Dubourg L, Carlier MC, et al. The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol. 2013;8:819\u201323.","journal-title":"Clin J Am Soc Nephrol"},{"key":"392_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000366449","volume":"128","author":"P Delanaye","year":"2014","unstructured":"Delanaye P, Krzesinski JM, Warling X, et al. Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron Clin Pract. 2014;128:127\u201334.","journal-title":"Nephron Clin Pract"},{"key":"392_CR12","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/ndt\/gfv043","volume":"30","author":"CY Yang","year":"2015","unstructured":"Yang CY, Chang ZF, Chau YP, et al. Circulating Wnt\/\u03b2-catenin signalling inhibitors and uraemic vascular calcifications. Nephrol Dial Transplant. 2015;30:1356\u201363.","journal-title":"Nephrol Dial Transplant"},{"key":"392_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/ckj\/sfv077","volume":"8","author":"A Kirkpantur","year":"2015","unstructured":"Kirkpantur A, Balci M, Turkvatan A, et al. Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients. Clin Kidney J. 2015;8:737\u201343.","journal-title":"Clin Kidney J"},{"key":"392_CR14","doi-asserted-by":"publisher","unstructured":"Kirkpantur A, Balci M, Turkvatan A, et al. Serum sclerostin levels, arteriovenous fistula calcification and 2-years all-cause mortality in prevalent hemodialysis patients Nefrologia. doi: \n                    10.1016\/j.nefro.2015.07.006\n                    \n                  .","DOI":"10.1016\/j.nefro.2015.07.006"},{"key":"392_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bone.2015.11.008","volume":"83","author":"KM Kim","year":"2015","unstructured":"Kim KM, Lim S, Moon JH, et al. Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease. Bone. 2015;83:178\u201383.","journal-title":"Bone"},{"key":"392_CR16","doi-asserted-by":"publisher","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","volume":"99","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Siriopol D, Saglam M, et al. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients. J Clin Endocrinol Metab. 2014;99:E1854\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"392_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/1471-2369-15-190","volume":"15","author":"FL Gon\u00e7alves","year":"2014","unstructured":"Gon\u00e7alves FL, Elias RM, dos Reis LM, et al. Serum sclerostin is an independent predictor of mortality in hemodialysis patients. BMC Nephrol. 2014;15:190.","journal-title":"BMC Nephrol"},{"key":"392_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/ndt\/gfu301","volume":"30","author":"C Drechsler","year":"2015","unstructured":"Drechsler C, Evenepoel P, Vervloet MG, et al. High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant. 2015;30:288\u201393.","journal-title":"Nephrol Dial Transplant"},{"key":"392_CR19","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1093\/ndt\/gft039","volume":"28","author":"L Viaene","year":"2013","unstructured":"Viaene L, Behets GJ, Claes K, et al. Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis? Nephrol Dial Transplant. 2013;28:3024\u201330.","journal-title":"Nephrol Dial Transplant"},{"key":"392_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/sdi.12415","volume":"28","author":"RM Moys\u00e9s","year":"2015","unstructured":"Moys\u00e9s RM, Schiavi SC. Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder. Semin Dial. 2015;28:578\u201386.","journal-title":"Semin Dial"},{"key":"392_CR21","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.2174\/092986707782794096","volume":"14","author":"PE Harrington","year":"2007","unstructured":"Harrington PE, Fotsch C. Calcium sensing receptor activators, calcimimetics. Curr Med Chem. 2007;14:3027\u201334.","journal-title":"Curr Med Chem"},{"key":"392_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bone.2009.07.082","volume":"46","author":"PJ Marie","year":"2010","unstructured":"Marie PJ. The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. Bone. 2010;46:571\u20136.","journal-title":"Bone"},{"key":"392_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","volume":"26","author":"P Raggi","year":"2011","unstructured":"Raggi P, Chertow GM, Torres PU, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011;26:1327\u201339.","journal-title":"Nephrol Dial Transplant"},{"key":"392_CR24","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2215\/CJN.01040308","volume":"3","author":"S Fishbane","year":"2008","unstructured":"Fishbane S, Shapiro WB, Corry DB, et al. Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. Clin J Am Soc Nephrol. 2008;3:1718\u201325.","journal-title":"Clin J Am Soc Nephrol"},{"key":"392_CR25","first-page":"176","volume":"64","author":"P Kuczera","year":"2013","unstructured":"Kuczera P, Adamczak M, Wi\u0119cek A. Safety and efficiency of treatment with cinacalcet of haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism. Endokrynol Pol. 2013;64:176\u201381.","journal-title":"Endokrynol Pol"},{"key":"392_CR26","first-page":"391","volume":"22","author":"A Bellasi","year":"2013","unstructured":"Bellasi A, Reiner M, P\u00e9tavy F, et al. Presence of valvular calcification predicts the response to cinacalcet: data from the ADVANCE study. J Heart Valve Dis. 2013;22:391\u20139.","journal-title":"J Heart Valve Dis"},{"key":"392_CR27","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/ki.2015.194","volume":"88","author":"AR Qureshi","year":"2015","unstructured":"Qureshi AR, Olauson H, Witasp A, Haarhaus M, Brandenburg V, Wernerson A, Lindholm B, S\u00f6derberg M, Wennberg L, Nordfors L, Ripsweden J, Barany P, Stenvinkel P. Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification. Kidney Int. 2015;88:1356\u201364.","journal-title":"Kidney Int"},{"key":"392_CR28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ki.2014.349","volume":"87","author":"GJ Behets","year":"2015","unstructured":"Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, D'Haese PC. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int. 2015;87:846\u201356.","journal-title":"Kidney Int"},{"key":"392_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1210\/jc.2013-3148","volume":"99","author":"B Dawson-Hughes","year":"2014","unstructured":"Dawson-Hughes B, Harris SS, Ceglia L, Palermo NJ. Serum sclerostin levels vary with season. J Clin Endocrinol Metab. 2014;99:149\u201352.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-016-0392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-016-0392-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-016-0392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T15:35:28Z","timestamp":1487691328000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-016-0392-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1186\/s12882-016-0392-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]},"article-number":"176"}}